Abstract:BACKGROUND Type 2 diabetes mellitus (T2DM) is a metabolic disease of impaired glucose utilization. Uncontrolled high sugar levels lead to advanced glycation end products (AGEs), which affects several metabolic pathways by its receptor of advanced glycation end products (RAGE) and causes diabetic complication. MiRNAs are small RNA molecules which regulate genes linked to diabetes and affect AGEs pathogenesis, and target tissues, influencing health and disease processes. AIM To explore miRNA roles in T2DM's metabolic pathways for potential therapeutic and diagnostic advancements in diabetes complications. METHODS We systematically searched the electronic database PubMed using keywords. We included free, full-length research articles that evaluate the role of miRNAs in T2DM and its complications, focusing on genetic and molecular disease mechanisms. After assessing the full-length papers of the shortlisted articles, we included 12 research articles. RESULTS Several types of miRNAs are linked in metabolic pathways which are affected by AGE/RAGE axis in T2DM and its complications. miR-96-5p, miR-7-5p, miR-132, has_circ_0071106, miR-143, miR-21, miR-145-5p, and more are associated with various aspects of T2DM, including disease risk, diagnostic markers, complications, and gene regulation. CONCLUSION Targeting the AGE/RAGE axis, with a focus on miRNA regulation, holds promise for managing T2DM and its complications. MiRNAs have therapeutic potential as they can influence the metabolic pathways affected by AGEs and RAGE, potentially reducing inflammation, oxidative stress, and vascular complications. Additionally, miRNAs may serve as early diagnostic biomarkers for T2DM. Further research in this area may lead to innovative therapeutic strategies for diabetes and its associated complications.

Emerging Roles of microRNAs as Biomarkers and Therapeutic Targets for Diabetic Neuropathy

Exploring the role of miRNA in diabetic neuropathy: from diagnostics to therapeutics

MicroRNA: A new generation therapeutic target in diabetic nephropathy

MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets

Non-coding RNAs in diabetic peripheral neuropathy: their role and mechanisms underlying their effects

New Perspectives and Prospects of microRNA Delivery in Diabetic Wound Healing

Emerging roles of exosomal miRNAs in diabetes mellitus

Deciphering the role of MicroRNAs in diabetic nephropathy: Regulatory mechanisms and molecular insights

The Importance of Non-Coding RNAs in Neurodegenerative Processes of Diabetes-Related Molecular Pathways

Understanding molecular mechanisms and miRNA-based targets in diabetes foot ulcers

MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics

Exosomal ncRNAs: Novel therapeutic target and biomarker for diabetic complications

Emerging roles of microRNAs as diagnostics and potential therapeutic interest in type 2 diabetes mellitus

Regulatory Roles of MicroRNAs in Diabetes

Treatment of diabetic peripheral neuropathy with engineered mesenchymal stromal cell-derived exosomes enriched with microRNA-146a provide amplified therapeutic efficacy

Recent Advances in Biomolecular Patho-Mechanistic Pathways behind the Development and Progression of Diabetic Neuropathy

Role of microRNAs in diabetic foot ulcers: Mechanisms and possible interventions

MicroRNAs in Control of Gene Regulatory Programs in Diabetic Vasculopathy.

A new frontier for the research of diabetic molecular biology: A microRNAs application in β-cell biology, insulin resistance, diabetes and its complications

Role of exosome-derived miRNAs in diabetic wound angiogenesis

Current Insights into miRNA and lncRNA Dysregulation in Diabetes: Signal Transduction, Clinical Trials and Biomarker Discovery